Cancer Care Network Has Updated Treatment Pathways
Physicians are using direct patient feedback to adjust how they approach care for those with complex health needs.
Updated on Oct. 7, 2026 in Cancer
Live Poll
Do you trust medical treatment decisions that incorporate patient-reported outcomes over clinical trial data alone?
The OneOncology network has integrated patient-reported outcomes into its clinical treatment pathways to better guide cancer care. This initiative aims to address the gap between traditional clinical trial data and the realities of patients treated in community practices across the United States.
Why it matters
Clinical trials frequently exclude older adults or individuals managing multiple comorbidities, leading to a knowledge gap in real-world settings. Incorporating direct patient data allows physicians to make more informed treatment decisions that reflect the diverse needs of their actual patient populations.
OneOncology utilizes disease groups to synthesize electronic patient-reported outcomes from over 30 practices nationwide. This approach represents a shift from trial-only findings to data that includes patients typically underrepresented in research, though the efficacy of this model is still being measured.
The players
OneOncology
A national network of oncology practices that provides physician-led, evidence-based cancer care across the United States.
The details
The network relies on disease groups composed of physicians from across the country to design evidence-based treatment pathways. By integrating electronic patient-reported outcomes directly into the decision-making process, clinicians can account for factors often missed in controlled trials. This ensures that care strategies reflect the lived experiences of patients who may have multiple health conditions.
Timeline
October 7, 2026: The initiative details were published.
Health Landscape
This development follows the pattern set by the NCI Community Oncology Research Program, which seeks to bring evidence-based research into local settings. It marks a departure from reliance on narrow clinical trial cohorts by prioritizing data from the broader patient population.
If you are managing cancer, ask your oncology team how they collect and utilize patient-reported outcomes to tailor your treatment plan. Discuss whether your specific health history and comorbidities are fully represented in the evidence your care team uses to select therapies.
The takeaway
Real-world data is increasingly vital to ensuring that cancer treatments work safely for patients who fall outside of narrow study criteria. If you have concerns about how a treatment might affect you due to other health conditions, make it a priority to discuss these factors with your physician.
Further reading
Learn more about the latest innovations in clinical care within our Cancer section.
Source note: This article includes information reported by Ajmc.
Live Poll
Do you trust medical treatment decisions that incorporate patient-reported outcomes over clinical trial data alone?
